PHARMA | PHARMANIAGA BHD*

2.47 (-0.8%)
Last updated: 17:00
Fundamental   3.3  
Technical   1.8  
Total Score   5.1  

 MT Sell-   ST Sell- 
PHARMA | PHARMANIAGA BHD

iSaham Fundamental Trend - PHARMA

FCON: 0.56 | Sharpe Ratio: -1.11 | LTS: 2.96



Financial Ratios - PHARMA



EPS 18.59 sen
Trailing PE (Sector Median: 18.7) 13.3
PEG -1.44
Altman Z 1.3
Beaver -0.004
Current Ratio 0.82
Debt-Equity (DE) Ratio 2.55
FCF Yield -3.33 %
Dividend Per Share (DPS) 15.5 sen
Revenue QoQ 3.29 %
Revenue YoY 7.7 %
Profit QoQ 72.06 %
Profit YoY 0.26 %
NTA QoQ -0.5 %
Profit Margin (Sector Median: 5.2) 1.88 %
ROE 8.96 %
ROIC 8.96 %
Dividend Yield (DY) 6.28 %

Support & Resistance

ATR Trailing Stop: 2.53

Support
Last Price
Resistance
Price 2.4 2.44 2.45 2.46 2.47 2.47 2.47 2.55 2.57 2.58 2.59
Volume (M) 0.7 0.4 0.2 1.2 3.3 3.3 1.2 1.1 0.7 1.6

Gann Support (EP/CL): 2.41/2.33 | Resistance (TP): 2.49/2.57

*Highlighted column shows significant volume at the support or resistance area.


Technical Trend


Moving Average Trend
Volume Trend


Trading Signalsbeta - PHARMA

Based on iSaham Screeners

Moving Average (Short Term) SELL
Moving Average (Mid Term) SELL
Moving Average (Long Term) SELL
Ichimoku Kumo HOLD
Bollinger Band -
RSI SELL
Stochastic SELL
Heikin-Ashi HOLD
MACD SELL
Solid MA Trend -
SAT SELL
Sector Trend (Long Term) SELL
Sector Trend (Short Term) SELL
Institutional Holdings -
Beat The Insti -
Magic Formula -
Better Than ASB -
52-Week High -
BTST -
T+ -
Candlestick -
Chart Pattern -

Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.

Fair Value

iSaham Fair Value: 1.6

Discounted Cash Flow (DCF)5.0% Growth 1.6
Discounted Cash Flow (DCF)-9.8% Growth 0.88
Relative Valuation 3.47
Graham Formula 1.22
Graham Number 2.74
Net Tangible Asset (NTA) 1.99


Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 79.66
Expected Revenue (M) 4475.19
Expected Growth (%) 15.0


Summary

Market Cap: 642 M.

Number of Shares: 260 M.

Float: 31.79%.

Stock highly correlated with

MSPORTS (95%)

GLOMAC (94%)

BHIC (93%)

BORNOIL (93%)

Pharmaniaga Berhad, through its subsidiaries, operates as an integrated healthcare company. It is engaged in the logistics and distribution; sale and marketing; and research, development, and manufacture of generic pharmaceuticals, as well as the supply of medical products and services; hospital equipping; and provision of information technology solutions. It is also involved in the sale and distribution of portable medical devices; contract manufacturing; and distribution and trade of pharmaceuticals products, food supplements, and diagnostics products. Pharmaniaga sells its products and services to the public and private sectors primarily in Malaysia and Indonesia. The company was founded in 1994 and is based in Shah Alam, Malaysia. Pharmaniaga Bhd operates as a member of UEM Group.

Code: 7081

Website: http://www.pharmaniaga.com/

Related Links: Bursa | Analyst Report | Annual Report | Announcement

AGM Doorgift: RM40 Royale Chulan Voucher [min 500 unit] (2017) | AGM Announcement

Top Shareholdings

Updated on 28-Feb-2019

Shareholder Value (M)
Boustead Holding Berhad 360.89
Lembaga Tabung Angkatan Tentera 72.26
Che Lodin Bin Wok Kamaruddin 30.88
Urusharta Jamaah Sdn Bhd 28.62
Valuecap Sdn Bhd 22.46
Kumpulan Wang Persaraan (Diperbadankan) 14.58
Yayasan Hasanah 6.52
Dasar Technologies Sdn Bhd 4.82
Au Kwan Seng 4.47
Chinchoo Investment Sdn. Berhad 2.26
Yong Siew Yoon 2.0
Gan Teng Siew Realty Sdn. Berhad 1.62
Au Kwan Seng 1.59
Yayasan Warisan Perajurit 1.47
Dfa Emerging Markets Small Cap Series 1.45
Employees Provident Fund Board 1.39
Tan Heng Loon 1.38
Uob Kay Hian Pte Ltd 1.33
Key Development Sdn. Berhad 1.31
Emerging Market Core Equity Portfolio DFA Investment Dimensions Group Inc 1.23
Tan Ewe Seong 1.11
Gemas Bahru Estates Sdn. Bhd. 1.07
Gan Yen Cheng 1.04
Bidor Tahan Estates Sdn.Bhd. 0.99
Mikdavid Sdn Bhd 0.9
Wong Wai Kuan 0.89
Mak Seng Fook 0.82
Rengo Malay Estate Sendirian Berhad 0.79